Verdict91/ 100
Grade A− · #2Eden
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit EdenHead-to-head verdict
Eden vs HealthRX
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict86/ 100
Grade B · #8HealthRX
A rare oral GLP tablet alongside both injectables, with the full plan table published on-site — though the headline $99 and $179 rates are 12-month prepay floors, not what a month-to-month patient pays.
Visit HealthRXThe verdict
Winner: Eden
Eden takes it with a higher Verdict Score — 91/100 to 86/100 (grade A− vs B). People who prioritize a vetted, high-transparency provider over the lowest sticker price. HealthRX still earns its place — patients who want a physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
90Real-world results85
90
Real-world results85
89Price honesty85
89
Price honesty85
95Prescriber access89
95
Prescriber access89
86Formulary choice90
86
Formulary choice90
90Cancellation fairness84
90
Cancellation fairness84
92Member support84
92
Member support84
Price, coverage & features
| Metric | Eden | HealthRX |
|---|---|---|
| Verdict Score | 91/100 | 86/100 |
| Grade | A− | B |
| Semaglutide | $239/mo | $99/mo (annual) |
| Tirzepatide | $349/mo | $179/mo (annual) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
Eden
What we like
- High verification confidence — clear supply-chain and clinician disclosure
- Nationwide availability
- Both molecules offered
The caveats
- Premium pricing vs the cheapest tiers
- Compounded only — no brand-name access
- FDA issued a warning letter to Eden Health International Inc. dba Eden in June 2026; it is public in FDA's warning-letter database
HealthRX
What we like
- Physician-supervised intake with licensed prescribers
- Carries both molecules plus a rare oral GLP tablet — real route choice
- Full plan table published on-site with a current-as-of date: semaglutide $190/mo month-to-month down to $99/mo on the 12-month plan, tirzepatide $239/mo down to $179/mo — no insurance required
- Cancel online in one click, unshipped doses refunded, 30-day money-back guarantee and a full refund if a provider doesn't approve you
The caveats
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- The advertised $99 and $179 rates require a 12-month prepay — $1,188 and $2,148 up front; month-to-month runs $190 and $239
- Brand Ozempic is pass-through at ~$1,299/mo — the path exists but is priced out of reach for most
Our pick — visit
People who prioritize a vetted, high-transparency provider over the lowest sticker price.
Visit Eden Read the full Eden review →Also worth a look
Patients who want a physician-supervised operator, would rather swallow a daily tablet than inject, and are willing to prepay a year to reach the lowest published rate.
Visit HealthRX Read the full HealthRX review →Keep comparing
Neither of these has to be the answer: the rivals we rank against Eden cover the 7 programs closest to it, and the same shortlist for HealthRX does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.